Cargando…
Upregulation of Complement Factor H by SOCS-1/3–STAT4 in Lung Cancer
Complement factor H (CFH) is a fluid phase regulator of complement proteins and functions to prevent complement attack and immune surveillance. CFH is known to inactivate therapeutic antibody-dependent complement-mediated cellular cytotoxicity. We found that CFH was highly expressed in human lung ca...
Autores principales: | Yoon, Yeon-Hee, Hwang, Hyeon-Ji, Sung, Hye-Jin, Heo, Sun-Hee, Kim, Dong-Sun, Hong, Su-Hyung, Lee, Kang-Hoon, Cho, Je-Yoel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520728/ https://www.ncbi.nlm.nih.gov/pubmed/30987235 http://dx.doi.org/10.3390/cancers11040471 |
Ejemplares similares
-
ELK3 Suppresses Angiogenesis by Inhibiting the Transcriptional Activity of ETS-1 on MT1-MMP
por: Heo, Sun-Hee, et al.
Publicado: (2014) -
Long Non-Coding RNA Associated with Cholesterol Homeostasis and Its Involvement in Metabolic Diseases
por: Lee, Kang-Hoon, et al.
Publicado: (2020) -
ABCA9, an ER cholesterol transporter, inhibits breast cancer cell proliferation via SREBP‐2 signaling
por: Hwang, Hyeon‐Ji, et al.
Publicado: (2023) -
SOCS1 and SOCS3 are expressed in mononuclear cells in human cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation
por: Shin, Seung-Hwan, et al.
Publicado: (2015) -
CUEDC2 controls osteoblast differentiation and bone formation via SOCS3–STAT3 pathway
por: Kim, Jung-Woo, et al.
Publicado: (2020)